News - GlaxoSmithKline

Filter

Current filters:

GlaxoSmithKline

Popular Filters

176 to 200 of 452 results

GlaxoSmithKline files for expanded use for Votrient

07-08-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) says it has submitted a request to the European Medicines…

EuropeGlaxoSmithKlineOncologyPharmaceuticalRegulationVotrient

US FDA approves shipment of quadrivalent flu vaccine to health care providers

06-08-2013

The US subsidiary of UK pharma giant GlaxoSmithKline (LSE: GSK) says it has received Food and Drug Administration…

Anti-viralsFluarixGlaxoSmithKlineNorth AmericaPharmaceuticalRegulationVaccines

US PDUFA for GSK diabetes drug delayed

03-08-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) revealed on Friday (August 2) that the US Prescription Drug…

albiglutideDiabetesGlaxoSmithKlineNorth AmericaPharmaceuticalRegulation

Another blow for Pharma, as India revokes Tykerb patent

02-08-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) has confirmed that India's Intellectual Property Appellate…

Asia-PacificGlaxoSmithKlineLegalOncologyPatentsPharmaceuticalTykerb

GAVI Alliance gets reduced price offers from Pfizer and GSK

30-07-2013

The price that the GAVI Alliance, a public/private partnership, pays for lifesaving pneumococcal vaccines…

GlaxoSmithKlineGlobalPfizerPharmaceuticalPricingVaccines

Slow uptake of HPV vaccine in USA "risks health of next generation"

29-07-2013

US human papillomavirus (HPV) vaccination rates in girls aged 13-17 years failed to increase between…

CervarixGardasilGlaxoSmithKlineHealthcareMerck & CoNorth AmericaPharmaceuticalVaccines

More details emerge of GSK China bribery allegations

26-07-2013

The extent of the alleged bribery and tax-related violations by UK pharma major GlaxoSmithKline (LSE:…

Asia-PacificGlaxoSmithKlineLegalPharmaceutical

GlaxoSmithKline 2nd-qtr sales up 2% but EPS falls 14%

24-07-2013

UK pharma giant GlaxoSmithKline posted second-quarter 2013 financial results showing that turnover increased…

FinancialGlaxoSmithKlinePharmaceutical

GSK's Revolade recommended by UK's NICE for low blood platelet counts

24-07-2013

The UK's drugs watch dog the National Institute for Health and Care Excellence (NICE) has recommended…

EuropeGlaxoSmithKlinePharmaceuticalRegulationRevolade

US appeals court reverses paroxetine order in favor of Mylan

23-07-2013

US generic drugmaker Mylan (Nasdaq: MYL) today (July 23) announced that the US Third Circuit Court of…

ApotexGenericsGlaxoSmithKlineLegalMylan LaboratoriesNeurologicalNorth AmericaparoxetinePatentsPaxil

Investigation on-going as claims GSK staff may have broken Chinese law

22-07-2013

Sales staff at UK pharma major GlaxoSmithKline (LSE: GSK) in China may have broken Chinese law, the company…

Asia-PacificGlaxoSmithKlineLegalPharmaceutical

China says GSK probe part of business climate clean-up

17-07-2013

China's probe into UK pharma major GlaxoSmithKline (LSE: GSK) was part of the country's efforts to improve…

Asia-PacificGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

US Court denies re-hearing of Arzerra patent case

16-07-2013

Danish drugmaker Genmab (OMX: GEN) says that the US Court of Appeals for the Federal Circuit has declined…

ArzerraBiogen IdecBiotechnologyGenentechGenmabGlaxoSmithKlineLegalNorth AmericaOncologyPatentsPharmaceutical

China probe into GlaxoSmithKline bribery allegations escalates

16-07-2013

Investigations in China relating to alleged bribery and tax-related crimes by UK pharma giant GlaxoSmithKline…

Asia-PacificGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

GlaxoSmithKline and Theravance withdraw Japan NDA for Relvar Ellipta in COPD

12-07-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) and US partner Theravance (Nasdaq: THRX) revealed on Friday…

Asia-PacificBiotechnologyGlaxoSmithKlinePharmaceuticalRegulationRelvar ElliptaRespiratory and PulmonaryTheravance

GSK executives investigated in China over bribery and tax-related crimes

11-07-2013

Executives at UK pharma giant GlaxoSmithKline (LSE: GSK) in China are being investigated on suspicion…

Asia-PacificBotoxGlaxoSmithKlinePharmaceuticalPricing

GlaxoSmithKline files sNDAs for combination melanoma drugs

09-07-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) said today (July 9) that it has submitted supplemental New…

BiotechnologyGlaxoSmithKlineMekinistNorth AmericaOncologyPharmaceuticalRegulationTafinlar

Immunocore in multi-million deal with GlaxoSmithKline on ImmTACs

09-07-2013

Oxford, UK-based biotech firm Immunocore, focused on developing novel biological drugs called ImmTACs…

Anti-viralsBiotechnologyGlaxoSmithKlineImmunocoreLicensingOncologyPharmaceuticalResearch

176 to 200 of 452 results

Back to top